These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 23174568)

  • 1. Pemphigoid with autoantibodies to all laminin 332 subunits and BP230 developing vesicles within psoriatic plaques.
    Ohata C; Mori Y; Tokita T; Koga H; Ohyama B; Sogame R; Hamada T; Ishii N; Furumura M; Hashimoto T
    Eur J Dermatol; 2012; 22(6):812-3. PubMed ID: 23174568
    [No Abstract]   [Full Text] [Related]  

  • 2. Subepidermal blistering disease with 3 distinct autoantibodies: anti-BP230, anti-laminin gamma-1, and anti-laminin-332.
    Kikuchi K; Natsuga K; Shinkuma S; Nishie W; Kajita S; Sato H; Shimizu H
    J Am Acad Dermatol; 2011 Oct; 65(4):878-880. PubMed ID: 21920249
    [No Abstract]   [Full Text] [Related]  

  • 3. Bullous pemphigoid with IgG autoantibodies to the α3 subunit of laminin 332 associated with psoriasis vulgaris.
    Ohashi M; Takagi H; Mizutani Y; Seishima M; Koga H; Hashimoto T
    Eur J Dermatol; 2017 Jun; 27(3):306-307. PubMed ID: 28468743
    [No Abstract]   [Full Text] [Related]  

  • 4. Anti-laminin γ1 pemphigoid associated with ulcerative colitis and psoriasis vulgaris showing autoantibodies to laminin γ1, type XVII collagen and laminin-332.
    Akasaka E; Nakano H; Korekawa A; Fukui T; Kaneko T; Koga H; Hashimoto T; Sawamura D
    Eur J Dermatol; 2015 Apr; 25(2):198-9. PubMed ID: 25787875
    [No Abstract]   [Full Text] [Related]  

  • 5. A case of cicatricial pemphigoid with simultaneous IgG autoantibodies against the 180 kd bullous pemphigoid antigen and laminin 5.
    Kawahara Y; Amagai M; Ohata Y; Ishii K; Hasegawa Y; Hsu R; Yee C; Yancey KB; Nishikawa T
    J Am Acad Dermatol; 1998 Apr; 38(4):624-7. PubMed ID: 9555805
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum levels of IgE anti-BP180 and anti-BP230 autoantibodies in patients with bullous pemphigoid.
    Ishiura N; Fujimoto M; Watanabe R; Nakashima H; Kuwano Y; Yazawa N; Echigo T; Okochi H; Tamaki K
    J Dermatol Sci; 2008 Feb; 49(2):153-61. PubMed ID: 17920818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IgG antibodies against immunodominant C-terminal epitopes of BP230 do not induce skin blistering in mice.
    Feldrihan V; Licarete E; Florea F; Cristea V; Popescu O; Sitaru C; Chiriac MT
    Hum Immunol; 2014 Apr; 75(4):354-63. PubMed ID: 24468586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case of pemphigoid vegetans positive with both BP180 and BP230 in enzyme-linked immunosorbent assays.
    Nagamoto E; Fujisawa A; Jinnin M; Koga H; Ishii N; Hashimoto T; Yoshino Y
    J Dermatol; 2014 Jul; 41(7):667-8. PubMed ID: 24985550
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical and immunologic factors associated with bullous pemphigoid relapse during the first year of treatment: a multicenter, prospective study.
    Fichel F; Barbe C; Joly P; Bedane C; Vabres P; Truchetet F; Aubin F; Michel C; Jegou J; Grange F; Antonicelli F; Bernard P
    JAMA Dermatol; 2014 Jan; 150(1):25-33. PubMed ID: 24226428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and immunological factors associated with bullous pemphigoid relapse.
    Fine JD
    JAMA Dermatol; 2014 Jan; 150(1):34. PubMed ID: 24226151
    [No Abstract]   [Full Text] [Related]  

  • 11. IgG autoantibodies from bullous pemphigoid patients recognize multiple antigenic reactive sites located predominantly within the B and C subdomains of the COOH-terminus of BP230.
    Skaria M; Jaunin F; Hunziker T; Riou S; Schumann H; Bruckner-Tuderman L; Hertl M; Bernard P; Saurat JH; Favre B; Borradori L
    J Invest Dermatol; 2000 May; 114(5):998-1004. PubMed ID: 10771483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of BP230 enzyme-linked immunosorbent assay in the diagnosis and immunological follow-up of bullous pemphigoid.
    Le Saché-de Peufeilhoux L; Ingen-Housz-Oro S; Hue S; Sbidian E; Valeyrie-Allanore L; Ortonne N; Roujeau JC; Wolkenstein P; Chosidow O; André C
    Dermatology; 2012; 224(2):154-9. PubMed ID: 22516798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and clinical significance of anti-laminin 332 autoantibodies detected by a novel enzyme-linked immunosorbent assay in mucous membrane pemphigoid.
    Bernard P; Antonicelli F; Bedane C; Joly P; Le Roux-Villet C; Duvert-Lehembre S; Rousselle P; Prost-Squarcioni C
    JAMA Dermatol; 2013 May; 149(5):533-40. PubMed ID: 23426192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association of multiple sclerosis with bullous pemphigoid: is there a shared antigen response?
    Taghipour K; Kirtschig G; Palace J; Groves RW; Venning V; Wojnarowska F
    J Am Acad Dermatol; 2012 Jul; 67(1):160-1. PubMed ID: 22703914
    [No Abstract]   [Full Text] [Related]  

  • 15. Anti-laminin-332 mucous membrane pemphigoid with autoantibodies to α3, β3 and γ2 subunits of laminin-332 as well as to BP230 and periplakin associated with adenocarcinoma from an unknown primary site.
    Fukuchi O; Suko A; Matsuzaki H; Baba H; Yoshida H; Takeuchi T; Odawara S; Fukuda S; Hashimoto T
    J Dermatol; 2013 Jan; 40(1):61-2. PubMed ID: 22901273
    [No Abstract]   [Full Text] [Related]  

  • 16. IgE recognition of bullous pemphigoid (BP)180 and BP230 in BP patients and elderly individuals with pruritic dermatoses.
    Fania L; Caldarola G; Müller R; Brandt O; Pellicano R; Feliciani C; Hertl M
    Clin Immunol; 2012 Jun; 143(3):236-45. PubMed ID: 22534318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant bullous pemphigoid and dermatitis herpetiformis.
    Schulze F; van Beek N; Terheyden P; Zillikens D; Schmidt E
    Dermatology; 2013; 226(3):217-21. PubMed ID: 23775006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Demonstration of epitope-spreading phenomena in bullous pemphigoid: results of a prospective multicenter study.
    Di Zenzo G; Thoma-Uszynski S; Calabresi V; Fontao L; Hofmann SC; Lacour JP; Sera F; Bruckner-Tuderman L; Zambruno G; Borradori L; Hertl M
    J Invest Dermatol; 2011 Nov; 131(11):2271-80. PubMed ID: 21697892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case of anti-laminin-gamma1 pemphigoid associated with psoriatic erythroderma.
    Kaminaka C; Kanazawa N; Furukawa F; Hashimoto T
    J Dermatol; 2010 Mar; 37(3):272-5. PubMed ID: 20507394
    [No Abstract]   [Full Text] [Related]  

  • 20. Blistering insights into the pathogenesis of bullous pemphigoid.
    Wong HK; Bechtel MA
    Clin Immunol; 2012 Feb; 142(2):101-4. PubMed ID: 22217422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.